Tweet from EricTopol at August 17, 2022 at 02:03PM
A randomized, placebo-controlled trial of 3 different drugs for Covid—metformin, ivermectin, or fluvoxamine—all of which failed to benefit with respect to primary endpoint, possible metformin benefit for a 2° endpoint
by @BramanteCarolyn and colleagues
https://t.co/37zFMRvq8F https://t.co/ntmA0HBrvF— Eric Topol (@EricTopol)
Aug 17, 2022
from http://twitter.com/EricTopol